<?xml version='1.0' encoding='utf-8'?>
<document id="17284510"><sentence text="Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol/norgestimate in healthy females."><entity charOffset="26-35" id="DDI-PubMed.17284510.s1.e0" text="rifaximin" /><entity charOffset="63-80" id="DDI-PubMed.17284510.s1.e1" text="ethinyl estradiol" /><entity charOffset="81-93" id="DDI-PubMed.17284510.s1.e2" text="norgestimate" /><pair ddi="false" e1="DDI-PubMed.17284510.s1.e0" e2="DDI-PubMed.17284510.s1.e0" /><pair ddi="false" e1="DDI-PubMed.17284510.s1.e0" e2="DDI-PubMed.17284510.s1.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s1.e0" e2="DDI-PubMed.17284510.s1.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s1.e1" e2="DDI-PubMed.17284510.s1.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s1.e1" e2="DDI-PubMed.17284510.s1.e2" /></sentence><sentence text="Rifaximin is an oral rifampin analog, and its activity is targeted within the gastrointestinal tract"><entity charOffset="0-9" id="DDI-PubMed.17284510.s2.e0" text="Rifaximin" /><entity charOffset="21-29" id="DDI-PubMed.17284510.s2.e1" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.17284510.s2.e0" e2="DDI-PubMed.17284510.s2.e0" /><pair ddi="false" e1="DDI-PubMed.17284510.s2.e0" e2="DDI-PubMed.17284510.s2.e1" /></sentence><sentence text=" Some analogs induce the cytochrome P450 family of oxidative enzymes" /><sentence text=" Ethinyl estradiol (EE), commonly found in oral contraceptives (OCs), is a known CYP3A4 substrate"><entity charOffset="1-18" id="DDI-PubMed.17284510.s4.e0" text="Ethinyl estradiol" /><entity charOffset="20-22" id="DDI-PubMed.17284510.s4.e1" text="EE" /><pair ddi="false" e1="DDI-PubMed.17284510.s4.e0" e2="DDI-PubMed.17284510.s4.e0" /><pair ddi="false" e1="DDI-PubMed.17284510.s4.e0" e2="DDI-PubMed.17284510.s4.e1" /></sentence><sentence text="" /><sentence text="To determine the potential effect of rifaximin on EE and norgestimate pharmacokinetics"><entity charOffset="37-46" id="DDI-PubMed.17284510.s6.e0" text="rifaximin" /><entity charOffset="50-52" id="DDI-PubMed.17284510.s6.e1" text="EE" /><entity charOffset="57-69" id="DDI-PubMed.17284510.s6.e2" text="norgestimate" /><pair ddi="false" e1="DDI-PubMed.17284510.s6.e0" e2="DDI-PubMed.17284510.s6.e0" /><pair ddi="false" e1="DDI-PubMed.17284510.s6.e0" e2="DDI-PubMed.17284510.s6.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s6.e0" e2="DDI-PubMed.17284510.s6.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s6.e1" e2="DDI-PubMed.17284510.s6.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s6.e1" e2="DDI-PubMed.17284510.s6.e2" /></sentence><sentence text="" /><sentence text="In an open-label, crossover study, healthy females received a single dose of OC (EE 0"><entity charOffset="81-92" id="DDI-PubMed.17284510.s8.e0" text="EE" /></sentence><sentence text="07 mg/norgestimate 0"><entity charOffset="6-18" id="DDI-PubMed.17284510.s9.e0" text="norgestimate" /></sentence><sentence text="50 mg)" /><sentence text=" Following a 1 week washout period, individuals received rifaximin 200 mg every 8 hours for 3 days, with a single dose of OC administered with the ninth rifaximin dose"><entity charOffset="57-66" id="DDI-PubMed.17284510.s11.e0" text="rifaximin" /><entity charOffset="153-162" id="DDI-PubMed.17284510.s11.e1" text="rifaximin" /><pair ddi="false" e1="DDI-PubMed.17284510.s11.e0" e2="DDI-PubMed.17284510.s11.e0" /><pair ddi="false" e1="DDI-PubMed.17284510.s11.e0" e2="DDI-PubMed.17284510.s11.e1" /></sentence><sentence text=" During both treatment periods, blood samples were collected periodically for up to 96 hours after each OC dose" /><sentence text=" Plasma concentration-time profiles and pharmacokinetic parameters were characterized for EE and 2 major metabolites of norgestimate, norgestrel (NG) and 17-deacetyl norgestimate (17-DNGM)"><entity charOffset="120-132" id="DDI-PubMed.17284510.s13.e0" text="norgestimate" /><entity charOffset="134-144" id="DDI-PubMed.17284510.s13.e1" text="norgestrel" /><entity charOffset="146-148" id="DDI-PubMed.17284510.s13.e2" text="NG" /><entity charOffset="154-178" id="DDI-PubMed.17284510.s13.e3" text="17-deacetyl norgestimate" /><entity charOffset="180-187" id="DDI-PubMed.17284510.s13.e4" text="17-DNGM" /><entity charOffset="90-96" id="DDI-PubMed.17284510.s13.e5" text="EE" /><entity charOffset="184-190" id="DDI-PubMed.17284510.s13.e6" text="NG" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e5" e2="DDI-PubMed.17284510.s13.e5" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e5" e2="DDI-PubMed.17284510.s13.e0" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e5" e2="DDI-PubMed.17284510.s13.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e5" e2="DDI-PubMed.17284510.s13.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e5" e2="DDI-PubMed.17284510.s13.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e5" e2="DDI-PubMed.17284510.s13.e4" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e5" e2="DDI-PubMed.17284510.s13.e6" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e0" e2="DDI-PubMed.17284510.s13.e0" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e0" e2="DDI-PubMed.17284510.s13.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e0" e2="DDI-PubMed.17284510.s13.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e0" e2="DDI-PubMed.17284510.s13.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e0" e2="DDI-PubMed.17284510.s13.e4" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e0" e2="DDI-PubMed.17284510.s13.e6" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e1" e2="DDI-PubMed.17284510.s13.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e1" e2="DDI-PubMed.17284510.s13.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e1" e2="DDI-PubMed.17284510.s13.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e1" e2="DDI-PubMed.17284510.s13.e4" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e1" e2="DDI-PubMed.17284510.s13.e6" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e2" e2="DDI-PubMed.17284510.s13.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e2" e2="DDI-PubMed.17284510.s13.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e2" e2="DDI-PubMed.17284510.s13.e4" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e2" e2="DDI-PubMed.17284510.s13.e6" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e3" e2="DDI-PubMed.17284510.s13.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e3" e2="DDI-PubMed.17284510.s13.e4" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e3" e2="DDI-PubMed.17284510.s13.e6" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e4" e2="DDI-PubMed.17284510.s13.e4" /><pair ddi="false" e1="DDI-PubMed.17284510.s13.e4" e2="DDI-PubMed.17284510.s13.e6" /></sentence><sentence text=" A drug-drug interaction was confirmed if the 90% CI for the 2 treatment period comparison was outside the 80-125% limit" /><sentence text="" /><sentence text="Twenty-six of 28 women completed the study" /><sentence text=" No differences in pharmacokinetic parameters were observed for EE, NG, or 17-DNGM when a single dose of the OC was administered alone or with rifaximin"><entity charOffset="68-70" id="DDI-PubMed.17284510.s17.e0" text="NG" /><entity charOffset="75-82" id="DDI-PubMed.17284510.s17.e1" text="17-DNGM" /><entity charOffset="109-111" id="DDI-PubMed.17284510.s17.e2" text="OC" /><entity charOffset="143-152" id="DDI-PubMed.17284510.s17.e3" text="rifaximin" /><entity charOffset="64-72" id="DDI-PubMed.17284510.s17.e4" text="EE" /><entity charOffset="79-87" id="DDI-PubMed.17284510.s17.e5" text="NG" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e4" e2="DDI-PubMed.17284510.s17.e4" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e4" e2="DDI-PubMed.17284510.s17.e0" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e4" e2="DDI-PubMed.17284510.s17.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e4" e2="DDI-PubMed.17284510.s17.e5" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e4" e2="DDI-PubMed.17284510.s17.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e4" e2="DDI-PubMed.17284510.s17.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e0" e2="DDI-PubMed.17284510.s17.e0" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e0" e2="DDI-PubMed.17284510.s17.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e0" e2="DDI-PubMed.17284510.s17.e5" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e0" e2="DDI-PubMed.17284510.s17.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e0" e2="DDI-PubMed.17284510.s17.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e1" e2="DDI-PubMed.17284510.s17.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e1" e2="DDI-PubMed.17284510.s17.e5" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e1" e2="DDI-PubMed.17284510.s17.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e1" e2="DDI-PubMed.17284510.s17.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e5" e2="DDI-PubMed.17284510.s17.e5" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e5" e2="DDI-PubMed.17284510.s17.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e5" e2="DDI-PubMed.17284510.s17.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e2" e2="DDI-PubMed.17284510.s17.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s17.e2" e2="DDI-PubMed.17284510.s17.e3" /></sentence><sentence text=" In addition, the 90% CI for the bioavailability contrasts (OC alone vs OC with rifaximin) for the maximum plasma concentration, area under the plasma concentration-time curve from zero to the last measurable plasma concentration or to infinity for EE, NG, and 17-DNGM all ranged from 86-118%"><entity charOffset="22-24" id="DDI-PubMed.17284510.s18.e0" text="CI" /><entity charOffset="80-89" id="DDI-PubMed.17284510.s18.e1" text="rifaximin" /><entity charOffset="253-255" id="DDI-PubMed.17284510.s18.e2" text="NG" /><entity charOffset="261-268" id="DDI-PubMed.17284510.s18.e3" text="17-DNGM" /><entity charOffset="249-255" id="DDI-PubMed.17284510.s18.e4" text="EE" /><entity charOffset="265-271" id="DDI-PubMed.17284510.s18.e5" text="NG" /><entity charOffset="60-66" id="DDI-PubMed.17284510.s18.e6" text="OC" /><entity charOffset="72-78" id="DDI-PubMed.17284510.s18.e7" text="OC" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e0" e2="DDI-PubMed.17284510.s18.e0" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e0" e2="DDI-PubMed.17284510.s18.e6" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e0" e2="DDI-PubMed.17284510.s18.e7" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e0" e2="DDI-PubMed.17284510.s18.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e0" e2="DDI-PubMed.17284510.s18.e4" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e0" e2="DDI-PubMed.17284510.s18.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e0" e2="DDI-PubMed.17284510.s18.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e0" e2="DDI-PubMed.17284510.s18.e5" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e6" e2="DDI-PubMed.17284510.s18.e6" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e6" e2="DDI-PubMed.17284510.s18.e7" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e6" e2="DDI-PubMed.17284510.s18.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e6" e2="DDI-PubMed.17284510.s18.e4" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e6" e2="DDI-PubMed.17284510.s18.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e6" e2="DDI-PubMed.17284510.s18.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e6" e2="DDI-PubMed.17284510.s18.e5" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e7" e2="DDI-PubMed.17284510.s18.e7" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e7" e2="DDI-PubMed.17284510.s18.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e7" e2="DDI-PubMed.17284510.s18.e4" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e7" e2="DDI-PubMed.17284510.s18.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e7" e2="DDI-PubMed.17284510.s18.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e7" e2="DDI-PubMed.17284510.s18.e5" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e1" e2="DDI-PubMed.17284510.s18.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e1" e2="DDI-PubMed.17284510.s18.e4" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e1" e2="DDI-PubMed.17284510.s18.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e1" e2="DDI-PubMed.17284510.s18.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e1" e2="DDI-PubMed.17284510.s18.e5" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e4" e2="DDI-PubMed.17284510.s18.e4" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e4" e2="DDI-PubMed.17284510.s18.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e4" e2="DDI-PubMed.17284510.s18.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e4" e2="DDI-PubMed.17284510.s18.e5" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e2" e2="DDI-PubMed.17284510.s18.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e2" e2="DDI-PubMed.17284510.s18.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e2" e2="DDI-PubMed.17284510.s18.e5" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e3" e2="DDI-PubMed.17284510.s18.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s18.e3" e2="DDI-PubMed.17284510.s18.e5" /></sentence><sentence text=" These intervals were within the predefined range for equivalence; therefore, no interaction was observed between OC and rifaximin"><entity charOffset="121-130" id="DDI-PubMed.17284510.s19.e0" text="rifaximin" /><entity charOffset="114-122" id="DDI-PubMed.17284510.s19.e1" text="OC" /><pair ddi="false" e1="DDI-PubMed.17284510.s19.e1" e2="DDI-PubMed.17284510.s19.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s19.e1" e2="DDI-PubMed.17284510.s19.e0" /></sentence><sentence text=" Rifaximin was well tolerated"><entity charOffset="1-10" id="DDI-PubMed.17284510.s20.e0" text="Rifaximin" /></sentence><sentence text="" /><sentence text="Administration of a 3 day dosing regimen of oral rifaximin was well tolerated and did not alter the pharmacokinetics of a commonly used combination OC containing EE and norgestimate"><entity charOffset="49-58" id="DDI-PubMed.17284510.s22.e0" text="rifaximin" /><entity charOffset="169-181" id="DDI-PubMed.17284510.s22.e1" text="norgestimate" /><entity charOffset="162-173" id="DDI-PubMed.17284510.s22.e2" text="EE" /><entity charOffset="148-159" id="DDI-PubMed.17284510.s22.e3" text="OC" /><pair ddi="false" e1="DDI-PubMed.17284510.s22.e0" e2="DDI-PubMed.17284510.s22.e0" /><pair ddi="false" e1="DDI-PubMed.17284510.s22.e0" e2="DDI-PubMed.17284510.s22.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s22.e0" e2="DDI-PubMed.17284510.s22.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s22.e0" e2="DDI-PubMed.17284510.s22.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s22.e3" e2="DDI-PubMed.17284510.s22.e3" /><pair ddi="false" e1="DDI-PubMed.17284510.s22.e3" e2="DDI-PubMed.17284510.s22.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s22.e3" e2="DDI-PubMed.17284510.s22.e1" /><pair ddi="false" e1="DDI-PubMed.17284510.s22.e2" e2="DDI-PubMed.17284510.s22.e2" /><pair ddi="false" e1="DDI-PubMed.17284510.s22.e2" e2="DDI-PubMed.17284510.s22.e1" /></sentence><sentence text="" /></document>